Egyptian Drug Authority License
FRC was licensed by the Egyptian Drug Authority (EDA) to perform bioequivalence/ bioavailability and stability studies since 2019.
Iraq Ministry of Health Approval
FRC was licensed by the Egyptian Drug Authority (EDA) to perform bioequivalence studies since after successfully passing the inspection visit in October 2023.
GCP & GLP Certification by EDA
FRC was granted certificates of compliance with the Good Clinical Practices (GCP) & Good Laboratory Practices (GLP) by the Egyptian Drug Authority (EDA) after successfully passing the annual inspection visit in November 2020, and has been renewed in May 2024.
GCP Certificate
GLP Certificate
FRC quality management system has been approved by Alcumus ISOQAR
FRC quality management system has been approved by Alcumus ISOQAR and is compliant with the requirements of ISO 9001:2015
ISO 9001 2015 Certificate